Alendronate improves fasting plasma glucose and insulin sensitivity, and decreases insulin resistance in prediabetic osteopenic postmenopausal women: A randomized triple‐blind clinical trial

AIMS/INTRODUCTION: Postmenopausal women receive bisphosphonates for osteoporosis treatment. The effect of these medications on developing diabetes mellitus in prediabetic patients is yet to be investigated. We aimed to determine the effect of alendronate on plasma glucose, insulin indices of postmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Karimi Fard, Maryam, Aminorroaya, Ashraf, Kachuei, Ali, Salamat, Mohammad Reza, Hadi Alijanvand, Moluk, Aminorroaya Yamini, Sima, Karimifar, Mansoor, Feizi, Awat, Amini, Massoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497594/
https://www.ncbi.nlm.nih.gov/pubmed/30267620
http://dx.doi.org/10.1111/jdi.12944

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497594/
https://www.ncbi.nlm.nih.gov/pubmed/30267620
http://dx.doi.org/10.1111/jdi.12944

Ejemplares similares